Eukarion: Addressing intracellular targets

Emerging Company Profile

Eukarion: Addressing intracellular targets

For its first two years, Eukarion Inc. operated out of co-founder Bernard Malfroy's "garage." At that stage, Eukarion existed mainly to reach proof of concept and file patent claims on technology pioneered by Malfroy and co-founder Michel Baudry. The founders intended to apply their background in neuroscience to "applications that were broad by design: targets for drug development leading to many potential indications," said Malfroy, who is president and CEO. Eukarion now has two areas of research focused on

Read the full 878 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE